Interlink Healthcare Communications

Interlink Healthcare Communications
Interlink Healthcare Communications
(IHC) Group of Companies
989 Lenox Drive, Suite 300
Lawrenceville, NJ 08648
Phone: 609-406-9600 · Fax:609-406-9046
Email: · Web:
Founded: 1996
Parent company: Interpublic Group, New York, N.Y.

Officers: Larry Iaquinto, president.

Healthcare accounts: Bio-Imaging Technologies Inc.; CapMed Personal Health Record; Bristol-Myers Squibb: Avalide, Avapro, Emsam, oncology; Enzon: Depocyte, Oncaspar; GE Healthcare: Adreview, Myoview, Omnipaque, Omniscan, Optison, Visipaque; Merck: Januvia, MK 523A/B; Merck Vaccines: herpes zoster vaccine; Novartis: Myfortic, Neoral, Sandostatin, Simulect, Zometa; Organon: NuvaRing; Pfizer: PF-3512676; sanofi-aventis: Avalide, Avapro.

Accounts gained (7): Merck: Januvia (medical education), MK524 A/B (medical education); Merck Vaccines: herpes zoster vaccine (medical education); Pfizer: PF-3512676 (promotional AOR); Enzon: Depocyte (promotional AOR), Oncaspar (promotional AOR); Organon: global.

Accounts lost (1): Bristol-Myers Squibb: Pravachol (patent expiration); Novartis: Gleevec (account resigned); Bayer Healthcare: BAY 43-9006 (lost).

Services: Full-service healthcare advertising and promotion agency with comprehensive scientific communications and medical education capabilities. Specific capabilities include global branding, affiliate communication, sales force promotion, professional advertising, DTC/DTP, e-solutions, interactive media, video production, sales meetings, exhibit design/convention activities, advocate development, publication planning, speakers’ bureaus, patient education.

Divisions: Interlink Healthcare Communications, IneXel Medical Strategy and Communications.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions